Detailed answers about OPENIMMUNE FOUNDATION, including incorporation, status, business activity, and accounts information.
When was OPENIMMUNE FOUNDATION founded?
OPENIMMUNE FOUNDATION was officially incorporated on 16 September 2026 and is registered under company number 17462515. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is OPENIMMUNE FOUNDATION?
PRI/LBG/NSC (Private, Limited by guarantee, no share capital, use of 'Limited' exemption). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of OPENIMMUNE FOUNDATION?
OPENIMMUNE FOUNDATION's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does OPENIMMUNE FOUNDATION do?
OPENIMMUNE FOUNDATION operates in the following sector: 72110 - Research and experimental development on biotechnology. This provides insight into the company's primary business activity and industry focus.
What is OPENIMMUNE FOUNDATION's registered address?
The registered office address of OPENIMMUNE FOUNDATION is 125 Wood Street, London, United Kingdom, EC2V 7AW. This is the official address filed with Companies House for legal and statutory correspondence.
Is OPENIMMUNE FOUNDATION financially stable?
Financial accounts for OPENIMMUNE FOUNDATION are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.